Dicerna Pharmaceuticals
DRNA
#3633
Rank
NZ$5.07 B
Marketcap
$65.19
Share price
0.00%
Change (1 day)
17,910.73%
Change (1 year)

Revenue for Dicerna Pharmaceuticals (DRNA)

Revenue in 2021 (TTM): NZ$0.27 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current revenue is NZ$0.32 Billion. In 2020 the company made a revenue of NZ$0.28 Billion an increase over the revenue in the year 2019 that were of NZ$40.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dicerna Pharmaceuticals from 2017 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)NZ$0.27 B-1.67%
2020NZ$0.28 B587.36%
2019NZ$40.77 M287.05%
2018NZ$10.53 M171.23%
2017NZ$3.88 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.51 M-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$94.90 B 28,752.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.57 B 986.23%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.57 B 32,297.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$55.49 B 16,770.11%๐Ÿ‡บ๐Ÿ‡ธ USA